| Literature DB >> 19160458 |
Andreas Anders1, Stephen Watt, Jürg Bähler, Kenneth E Sawin.
Abstract
Fission yeast genes identified in genetic screens are usually cloned by transformation of mutants with plasmid libraries. However, for some genes this can be difficult, and positional cloning approaches are required. The mutation swi5-39 reduces recombination frequency in homozygous crosses and has been used as a tool in mapping gene position (Schmidt, 1993). However, strain construction in swi5-39-based mapping is significantly more laborious than is desirable. Here we describe a set of strains designed to make swi5-based mapping more efficient and more powerful. The first improvement is the use of a swi5Delta strain marked with kanamycin (G418) resistance, which greatly facilitates identification of swi5 mutants. The second improvement, which follows directly from the first, is the introduction of a large number of auxotrophic markers into mapping strains, increasing the likelihood of finding close linkage between a marker and the mutation of interest. We combine these new mapping strains with a rec12Delta-based approach for initial mapping of a mutation to an individual chromosome. Together, the two methods allow an approximate determination of map position in only a small number of crosses. We used these to determine that mod22-1, a modifier of microtubule nucleation phenotypes, encodes a truncation allele of Swr1, a chromatin-remodelling factor involved in nucleosomal deposition of H2A.Z histone variant Pht1. Expression microarray analysis of mod22-1, swr1Delta and pht1Delta cells suggests that the modifier phenotype of mod22-1 mutants may be due to small changes in expression of one or more genes involved in tubulin function. (c) 2009 John Wiley & Sons, Ltd.Entities:
Mesh:
Substances:
Year: 2008 PMID: 19160458 PMCID: PMC2964509 DOI: 10.1002/yea.1639
Source DB: PubMed Journal: Yeast ISSN: 0749-503X Impact factor: 3.239
Fission yeast strains used in this study
| Strain | Genotype | Mapping strain number | Source |
|---|---|---|---|
| KS3733 | Chr I A1 | This study | |
| KS3731 | Chr I A2 | This study | |
| KS3728 | Chr I A3 | This study | |
| KS3729 | Chr I A4 | This study | |
| KS3393 | Chr I B1 | This study | |
| KS3394 | Chr I B2 | This study | |
| KS3421 | Chr I B3 | This study | |
| KS3419 | Chr I B4 | This study | |
| KS3402 | Chr II A1 | This study | |
| KS3404 | Chr II A2 | This study | |
| KS3478 | Chr II A3 | This study | |
| KS3480 | Chr II A4 | This study | |
| KS4251 | Chr II B1 | This study | |
| KS4253 | Chr II B2 | This study | |
| KS4278 | Chr II B3 | This study | |
| KS4276 | Chr II B4 | This study | |
| KS4853 | Chr III A1 | This study | |
| KS4851 | Chr III A2 | This study | |
| KS4855 | Chr III A3 | This study | |
| KS4857 | Chr III A4 | This study | |
| KS3358 | Chr III B1 | This study | |
| KS3356 | Chr III B2 | This study | |
| KS3452 | Chr III B3 | This study | |
| KS3450 | Chr III B4 | This study | |
| KS516 | Laboratory stock | ||
| KS959 | Laboratory stock | ||
| KS963 | Laboratory stock | ||
| KS1470 | Laboratory stock | ||
| KS3250 | G. Smith | ||
| KS3320 | G. Smith | ||
| KS3322 | G. Smith | ||
| KS3349 | This study | ||
| KS3484 | This study | ||
| KS3488 | This study | ||
| KS3611 | This study | ||
| KS4348 | Bioneer | ||
| KS4350 | This study | ||
| KS4355 | Bioneer | ||
| KS4362 | This study | ||
| KS4367 | This study | ||
| KS4384 | This study | ||
| KS4555 | This study | ||
| KS4645 | Bioneer | ||
| KS4666 | This study |
Figure 3Venn diagrams showing numbers of genes changed in expression in mod22-1, swr1Δ and pht1Δ mutants, either unique to each mutant, common to pairs of mutants or common to all three mutants. (A) Genes with reduced expression in the mutants. (B) Genes with increased expression in the mutants
Figure 1Diagram showing the positions of markers for the six different mapping-strain chromosomes, drawn to scale with the genome sequence. Black circles, centromeres; grey-dashed regions, ribosomal DNA repeats at either end of chromosome III, which can vary in length (Pasero and Marilley, 1993)
Mapping strain markers
| Chromosome | Screening medium | Physical position on chromosome | Physical distance to next marker gene | Genetic distance |
|---|---|---|---|---|
| EMMG − U | 739 300 | 403 815 | 50 | |
| EMMG − M | 1 143 115 | 186 147 | 52 | |
| EMMG − A | 1 329 262 | 346 468 | 76 | |
| EMMG − K | 1 675 730 | 598 282 | 48 | |
| EMMG − R | 2 274 012 | 558 784 | 122 | |
| EMMG − H | 2 832 796 | 937 204 | 250 | |
| YE5S + CHX | 3 770 000 | 670 096 | 118 | |
| EMMG − L | 4 440 096 | 924 264 | 170 | |
| EMMG − A | 5 364 360 | N/A | N/A | |
| EMMG − A | 1 157 118 | 331 093 | 64 | |
| EMMG − H | 1 488 211 | 401 953 | 92 | |
| EMM + CAN | 1 890 164 | 84 324 | 32 | |
| EMMG − L | 1 974 488 | 714 104 | 100 | |
| EMMG − L | 2 688 592 | 817 459 | 140 | |
| EMMG − K | 3 506 051 | 588 597 | 188 | |
| EMMG − R | 4 094 648 | N/A | N/A | |
| EMMG − U | 115 781 | 1 200 556 | 260 | |
| EMMG − A | 1 316 337 | 296 987 | 100 | |
| EMMG − R | 1 613 324 | 799 041 | 144 | |
| EMMG − A | 2 412 365 | N/A | N/A | |
Physical positions are from GeneDB at the Wellcome Trust Sanger Institute (http://www.genedb.org/genedb/pombe/) on 8 May 2008. Genetic distances were estimated using the map of Munz et al. (1989).
met5 = met9.
Use sodium glutamate as nitrogen source. Ammonium chloride must not be used, as in our hands Ura- Ade- Arg- Lys+ strains and Ura−Met−His−Lys+ strains failed to grow on ammonium chloride-based medium lacking lysine. There reasons for this are not yet clear.
Exact position of cyh1 is unknown and therefore estimated from position of centromere, which is very closely linked.
Use ammonium chloride as nitrogen source. Sodium glutamate can be used as well, but ammonium chloride gives better results.
Exact position of can1 is unknown and therefore estimated from position of spo14, which is very closely linked.
N/A, not applicable.
Mapping of test genes by tetrad analysis
| Mapping strain | Test gene A | Marker B | Distance A–B (kb) | PD | NPD | T | N | PD | NPD | T | N | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chr I A | 521 | 14 | 1 | 29 | 44 | 40 | 61 | 24 | 0 | 0 | 24 | 0 | 0 | ||
| 925 | 13 | 4 | 27 | 44 | 58 | 80 | 22 | 0 | 2 | 24 | 4.2 | 4.4 | |||
| 1111 | 11 | 11 | 22 | 44 | ND | ND | 20 | 1 | 3 | 24 | 19 | 12 | |||
| 1457 | 11 | 7 | 26 | 44 | ND | ND | 19 | 1 | 4 | 24 | 21 | 14 | |||
| 2055 | 11 | 6 | 25 | 44 | ND | ND | 19 | 1 | 4 | 24 | 21 | 14 | |||
| 2614 | 8 | 3 | 23 | 44 | ND | ND | 18 | 1 | 5 | 24 | 23 | 17 | |||
| Chr I B | 1507 | 18 | 2 | 27 | 47 | 42 | 54 | ||||||||
| 838 | 30 | 0 | 17 | 47 | 18 | 22 | |||||||||
| 86 | 45 | 1 | 1 | 47 | 7.5 | 3.3 | |||||||||
| Chr II A | 756 | 8 | 9 | 44 | 61 | ND | ND | 16 | 0 | 12 | 28 | 21 | 28 | ||
| 1087 | 10 | 11 | 40 | 61 | ND | ND | 11 | 1 | 16 | 28 | 39 | 51 | |||
| 1489 | 11 | 14 | 36 | 61 | ND | ND | 9 | 3 | 16 | 28 | ND | ND | |||
| 1574 | 10 | 13 | 38 | 61 | ND | ND | 11 | 4 | 13 | 28 | ND | ND | |||
| Chr III A | 317 | 12 | 8 | 43 | 63 | ND | ND | 43 | 0 | 11 | 54 | 10.2 | 11.4 | ||
| 884 | 12 | 9 | 42 | 63 | ND | ND | 41 | 1 | 12 | 54 | 17 | 23 | |||
| 1181 | 17 | 4 | 42 | 63 | 52 | 79 | 33 | 3 | 18 | 54 | 33 | 29 | |||
| Chr III B | 436 | 13 | 4 | 39 | 56 | 56 | 91 | 35 | 0 | 11 | 46 | 12 | 14 | ||
| 363 | 13 | 8 | 35 | 56 | ND | ND | 43 | 0 | 3 | 46 | 3.3 | 3.4 | |||
Map distance dp is based on Perkins' formula, and map distance dl is derived from maximum likelihood estimate (see Materials and methods), as distances based on Perkins' formula are likely to be underestimates when NPD > 5% of total tetrads. ND, not determined, because data do not suggest linkage.
Distance determined retrospectively, after identification of mod22 as swr1.
Estimated distance; see Table 2.
PD, parental ditype; NPD, non-parental ditype; T, tetratype. Our criterion for linkage in tetrad analysis is PD > NPD, with statistical significance p < 0.05 by χ2 test. A more stringent criterion would be p < 0.01 (Kohli et al., 1977).
Mapping of test genes by random spore analysis
| Mapping strain | Test gene (A) | Marker (B) | Physical distance (A to B; kb) | Recombinants (%) | χ2 | |||
|---|---|---|---|---|---|---|---|---|
| Chr I B | 1507 | 49 | 120 | 0.033 | 0.8551 | |||
| 838 | 54 | 120 | 0.833 | 0.3613 | ||||
| 86 | 8 | 120 | 83.333 | < 0.0001 | ||||
| Chr II B | 1205 | 47 | 280 | 0.914 | 0.3390 | |||
| 387 | 44 | 280 | 3.657 | 0.0558 | ||||
| 201 | 25 | 280 | 68.014 | < 0.0001 | ||||
| Chr II B | 1205 | 13 | 560 | 306 | < 0.0001 | |||
| 387 | 7 | 560 | 414 | < 0.0001 | ||||
| 201 | 4 | 560 | 475 | < 0.0001 |
Distance determined retrospectively, after identification of mod22 as swr1.
Estimated distance; see Table 2.
Figure 2Allelism of mod22 and swr1, a gene encoding a chromatin-remodelling factor. (A) Schematic of fission yeast Swr1 protein, showing position of the nonsense mutation in mod22-1. Shaded areas indicate two regions of high identity (>75%) to budding yeast Swr1p. (B) Cell-shape phenotypes in the indicated mutants, showing synthetic effect of combining either mod22-1 or swr1Δ with gfh1Δ. (C) Cell-shape phenotypes in the indicated mutants, showing that swr1ΔC (a de novo-created truncation-equivalent of mod22-1), pht1Δ (deletion of fission yeast H2A.Z) and swc2Δ (deletion of a component of the SWR1–SWR-C complex) all have similar phenotypes to mod22-1 and swr1Δ. D. Rescue of the cell-shape phenotype of gfh1Δ mod22-1 double mutant by plasmid-based expression of wild-type Swr1